LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding

NFκB is a central mediator of inflammation. Present inhibitors of NFκB are mostly based on inhibition of essential machinery such as proteasome and protein kinases, or activation of nuclear receptors; as such, they are of limited therapeutic use due to severe toxicity. Here we report an LPS-induced...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Lee, Hwan Hee, Sanada, Satoru, An, Seung Min, Ye, Byeong Jin, Lee, Jun Ho, Seo, Young-Kyo, Lee, Changwook, Lee-Kwon, Whaseon, Küper, Christoph, Neuhofer, Wolfgang, Choi, Soo Youn, Kwon, Hyug Moo
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847014/
https://ncbi.nlm.nih.gov/pubmed/27118681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep24921
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы